Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Behçet's disease, a current disease].

P Godeau1, B Wechsler

  • 1Service de Médecine Interne, G.H. La Pitié-Salpétrière, Paris.

Journal Des Maladies Vasculaires
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of virtual fencing in a mountain environment and its impact on heifer behaviour and welfare.

Animal : an international journal of animal bioscience·2025
Same author

Risk factors for tail lesions in undocked fattening pigs reared on Swiss farms.

Schweizer Archiv fur Tierheilkunde·2020
Same author

Body size in relation to cubicle dimensions affects lying behavior and joint lesions in dairy cows.

Journal of dairy science·2020
Same author

Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?

Revue neurologique·2018
Same author

Effect of rubber mats and perforation in the lying area on claw and limb lesions of fattening pigs.

Animal : an international journal of animal bioscience·2018
Same author

Moderate lameness leads to marked behavioral changes in dairy cows.

Journal of dairy science·2018
Same journal

Renal function and venous thromboembolic diseases.

Journal des maladies vasculaires·2016
Same journal

[Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].

Journal des maladies vasculaires·2016
Same journal

[Erratum to "When to worry about before a vascular chronic leg ulcer?" [J. Mal. Vasc. 41 (2016) 307-314]].

Journal des maladies vasculaires·2016
Same journal

[Deep venous thrombosis of the upper limb in a violin player: The "bow syndrome"].

Journal des maladies vasculaires·2016
Same journal

[Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France].

Journal des maladies vasculaires·2016
Same journal

[Vitamin K antagonist, direct oral anticoagulants: Where is the truth?]

Journal des maladies vasculaires·2016
See all related articles

Behçet's disease treatment is symptomatic, with colchicine for mild mucocutaneous issues. Severe neurological and ophthalmological forms require steroids, with immunosuppressants reserved for refractory cases.

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Behçet's disease is a chronic inflammatory disorder with diverse manifestations.
  • Treatment strategies are tailored to disease severity and affected organ systems.

Purpose of the Study:

  • To outline current therapeutic approaches for Behçet's disease.
  • To emphasize the importance of individualized treatment plans and patient monitoring.

Main Methods:

  • Symptomatic management based on clinical presentation.
  • Pharmacological interventions including colchicine, NSAIDs, corticosteroids, and immunosuppressants.
  • Consideration of anticoagulation and plasmapheresis for specific complications.

Main Results:

Related Experiment Videos

  • Colchicine is effective for mucocutaneous symptoms and prevention of acute episodes.
  • Corticosteroids are crucial for severe neurological and ophthalmological involvement.
  • Immunosuppressants and cyclosporine are second-line options due to potential risks.
  • Anticoagulation and plasmapheresis address thrombotic and severe forms, respectively.

Conclusions:

  • Treatment of Behçet's disease requires a multidisciplinary approach.
  • Careful monitoring is essential to manage disease activity and treatment-related complications.
  • Patient adherence and early intervention are key to optimal outcomes in this chronic condition.